Boyu, Sinopharm among shortlisted bidders for drugmaker Mundipharma's China unit

Boyu, Sinopharm among shortlisted bidders for drugmaker Mundipharma's China unit

Photo: National Cancer Institute / Unsplash

Drugmaker Mundipharma has included Boyu Capital and state-owned Sinopharm on a shortlist of bidders for its Chinese business, two people familiar with the situation said.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter